Amlodipine Does Not Cause Hyponatremia
Amlodipine is not a recognized cause of hyponatremia and is not listed among medications that induce this electrolyte disturbance in major guidelines or FDA labeling. In a hypertensive patient presenting with hyponatremia (serum sodium 130 mmol/L), you should investigate other causes rather than attributing it to amlodipine.
Evidence from FDA Drug Labeling
The FDA-approved prescribing information for amlodipine makes no mention of hyponatremia as an adverse effect 1. The pharmacodynamic profile shows that amlodipine acts as a peripheral arterial vasodilator through calcium channel blockade, with effects on blood pressure but no documented impact on sodium homeostasis 1.
One pharmacokinetic study actually demonstrated that amlodipine may cause a small reduction in total body sodium (evidenced by increased plasma renin activity and decreased atrial natriuretic peptide), which would theoretically oppose hyponatremia development rather than cause it 2.
Guideline Recommendations on Electrolyte Monitoring
Current hypertension guidelines do not recommend routine electrolyte monitoring when prescribing calcium channel blockers, in stark contrast to recommendations for ACE inhibitors, ARBs, and diuretics 3, 4. The 2025 AHA/ACC guidelines specify that basic metabolic panels should be checked 2-4 weeks after initiation of diuretics, ACE inhibitors, ARBs, and mineralocorticoid receptor antagonists—but calcium channel blockers are notably absent from this list 3, 4.
The 2012 ESC guidelines on heart failure explicitly state that amlodipine is recommended as third-line therapy for persistent hypertension, with no warnings about hyponatremia 5. Similarly, the 2007 AHA scientific statement notes that amlodipine appeared safe in patients with severe systolic heart failure in the PRAISE trial, with no mention of electrolyte disturbances 6.
Actual Causes of Hyponatremia to Investigate
In your patient with hypertension and serum sodium 130 mmol/L, focus your diagnostic workup on established causes 7:
Medication Review
- Diuretics (thiazides cause hyponatremia more commonly than loops) 3, 4
- ACE inhibitors and ARBs (can cause hyponatremia, especially in combination) 3, 4
- Antidepressants (SSRIs, SNRIs) 8, 9
- Anticonvulsants (carbamazepine, oxcarbazepine) 8, 10, 9
- Antipsychotics 8, 9
Clinical Assessment
- Dietary sodium and fluid intake history 7
- Volume status determination (hypovolemic, euvolemic, or hypervolemic) 7, 11
- Bowel regimen review (excessive laxative use) 7
- Assessment for gastrointestinal bleeding 7
- Infectious workup including diagnostic paracentesis if ascites present 7
- Thyroid and adrenal function testing 7
Management Approach for This Patient
For asymptomatic hypervolemic hyponatremia with serum sodium 130 mmol/L, the 2025 AGA guidelines recommend 7:
- Fluid restriction to 1-1.5 L daily 7, 11
- Sodium restriction (though less stringent than fluid restriction) 7
- Modification or discontinuation of diuretics if present 7, 11
- Monitoring electrolytes to ensure sodium stabilizes >125 mmol/L before resuming diuretics 7
Continue amlodipine as it is not contributing to the hyponatremia and provides important blood pressure control 5, 3.
Rare Case Reports vs. Clinical Reality
While one 2025 case report described lercanidipine-induced hyponatremia in an elderly patient 12, and another described hyponatremia during hyperinsulinemia-euglycemia therapy for amlodipine overdose 13, these represent exceptional circumstances that do not establish causality for therapeutic amlodipine use. The overdose case involved massive fluid administration (6.9 L of dextrose with free water) as the actual cause 13.
A comprehensive 2014 review of drug-induced hyponatremia and a 2025 update both do not list calcium channel blockers among medications causing hyponatremia 8, 9.
Common Pitfall to Avoid
Do not discontinue amlodipine in a hypertensive patient with hyponatremia unless all other causes have been thoroughly excluded and the temporal relationship is compelling. The 2012 ESC guidelines specifically recommend amlodipine as add-on therapy for blood pressure control in heart failure patients 5, and the 2007 AHA statement confirms its safety profile 6.
Instead, investigate the true cause by checking for concurrent diuretic use, SIADH, adrenal insufficiency, hypothyroidism, or other established etiologies 7, 3, 4.